A second-line benefit is conditional on the experimental sequence.
In soman-exposed rats, perampanel given twenty minutes after midazolam reduced subsequent seizure burden, recurrent seizures and selected neurodegeneration measures compared with midazolam alone. EEG and tissue outcomes supplied different parts of the assessment.
The induced nerve-agent model differs from many human seizure emergencies. Added therapy was not a substitute tested before midazolam, and animal exposures cannot determine a human regimen. Reduced pathological markers do not establish complete neurological recovery.
Describe timing and sequence rather than labeling the drugs interchangeable. The study supports further investigation of adjunctive mechanisms. It cannot establish that delayed treatment caused an individual human outcome or that the same combination would overcome every form of benzodiazepine-resistant status epilepticus.
Source: PMC12362163, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Valproate After Benzodiazepines: Why a Pooled Status-Epilepticus Response Rate Needs Context.